AVEO PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aveo Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q3 2022.
  • Aveo Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $32K, a 94.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $32K -$528K -94.3% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $81K -$595K -88% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $130K -$660K -83.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $178K -$725K -80.3% Dec 31, 2021 10-Q 2022-11-07
Q3 2021 $560K -$452K -44.7% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $676K -$444K -39.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $790K -$435K -35.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $903K Dec 31, 2020 10-K 2022-03-14
Q3 2020 $1.01M Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.12M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.23M Mar 31, 2020 10-Q 2020-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.